May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
AFP Contributor / Contributor / Getty Images Johnson & Johnson on Wednesday proposed a settlement that would pay roughly $6.5 billion to settle lawsuits alleging the company's talc powder caused ...
that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered to pay $6.475 billion in response to thousands of lawsuits that have alleged ...
J&J will buy Momenta Pharmaceuticals for roughly $6.5 billion in cash, paving the way for its Janssen unit to expand its efforts into autoimmune disease treatments. J&J will pay $52.50 for each ...
Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ... The pharmaceutical giant is set to pay ...
Pharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its talc-based products, often associated with health concerns, caused cancer. This unprecedented ...
6月1日現在、PayPayで実施中/実施予定のキャンペーンを下表にまとめました。キャンペーン名を押すと、公式サイトで事前エントリーや詳しい ...
Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial The ruling comes as J&J continues to pursue a proposed $6.48 billion settlement of most talc-related lawsuits through a prepackaged ...
Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022 Even before Q4 numbers were released, JNJ started falling after a slew of new stories hit the press Even ...
Johnson & Johnson's (NYSE ... to the most recent total annual payment of $4.96. This works out to be a compound annual growth rate (CAGR) of approximately 6.5% a year over that time.
Johnson & Johnson is ordered to pay a $300 million punitive award to a woman who said she contracted cancer through the use of the company's talc-based products. Johnson & Johnson is ordered to ...